Relative Strength Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 06:00:00 04/08/26 am AEST			5-day change	1st Jan Change
3.010 ^USD	+3.44%		+6.74%	+9.45%

28/07	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
18/07	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PERSPECTIVE THERAPEUTICS, INC.	Other Biotechnology & Medical Research	+3.44%	+6.74%	+9.45%	-18.21%	-55.48%	332M